𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detailed analysis of cell cycle kinetics upon proteasome inhibition

✍ Scribed by Barbie M. Machiels; Mieke E. R. Henfling; Will L. H. Gerards; Jos L. V. Broers; Hans Bloemendal; Frans C. S. Ramaekers; Bert Schutte


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
275 KB
Volume
28
Category
Article
ISSN
0196-4763

No coin nor oath required. For personal study only.

✦ Synopsis


We have studied specific effects of proteasome inhibition on cell cycle progression. To this end, the protease inhibitors MG115, calpain inhibitor I, and calpain inhibitor II, which display differential inhibitory effects on proteasomes, were used. Cell kinetic studies using bromodeoxyuridine pulse labeling revealed a complete block of G1/S and metaphase transitions and a delayed progression through S phase in cell cultures treated with 54 Β΅M of MG115. Calpain inhibitor I in similar concentrations displayed a fivefold lower effect on cell cycle kinetics. Calpain inhibitor II and MG2M, which is a structural analogue of MG115, had no effect on the cell cycle. The inhibitory effect of MG115 treatment was reversible, because the cell cycle was immediately resumed when the MG115-containing culture medium was replaced by fresh culture medium. Because ubiquitinated proteins accumulated after MG115 treatment, it was confirmed that ubiquitin-dependent protein degradation, and thus proteasomal activity were blocked. By comparison of biochemical and in vitro proteasome inhibition experiments, it was hypothesized that chymotrypsin-like activity of proteasomes may play an important role in cell cycle kinetics.


πŸ“œ SIMILAR VOLUMES


Cell cycle kinetics analysis of Hela cel
✍ Seraj Y. Abed; Sufian M. ElAssouli; Osman S. Ozkul; Mustafa Alidrisi; Majed Amer πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science 🌐 English βš– 612 KB

A computer simulation model was developed and used to analyze the inhibitory effect of aphidicolin on the proliferation of Hela cells. Simulation results were compared with actual experimental results [Pedrali-Noy et al. (1980) Nuc. Acid Res. 8, 377] and were found to be in good agreement. Also, the

Synergistic antileukemic effect of two p
✍ Anders Ask; Lo Persson; Stina M. Oredsson; Olle Heby πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 French βš– 558 KB

alpha-Difluoromethylornithine (DFMO), an enzyme-activated irreversible inhibitor of ornithine decarboxylase, was used alone and in combination with multiple doses of methylglyoxal-bis(guanylhydrazone) (MGBG) to treat mice with systemic L1210 leukemia. Used as a single agent (administered p.o. as a 3

E2F1 identified by promoter and biochemi
✍ Roy Blum; Itay Nakdimon; Liat Goldberg; Ran Elkon; Ron Shamir; Gideon Rechavi; Y πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 690 KB

## Abstract Active Ras contributes to the malignant phenotype of glioblastoma multiforme. Recent studies showed that the Ras inhibitor farnesyl thiosalicylic acid downregulates the transcription factor hypoxia‐inducible factor‐1Ξ±, causing shutdown of glycolysis in U87 glioblastoma cells. Farnesyl t